Could you tell me what companies are involved here(with making and marketing). Just came across this news release.
newswire.ca
Video B-roll via satellite - a new drug that helps to speed the healing of diabetic foot ulcers
TORONTO, Feb. 11 /CNW/ - The following Video News Release footage is
available at the listed times and co-ordinates.
DATE OF FEED: Thursday, February 11, 1999
TIME OF FEED: 13:00 to 13:30 (ET)
CO-ORDINATES: ANIK E2, C-Band, Transponder 3B, Audio 6.2 & 6.8
PEGAD Available at: DOME TRANSMIT 1, DPA 18
STORY SUMMARY: A new biotechnology wound healing therapeutic that both
enhances and speeds healing has recently been approved by Health Canada's
Therapeutic Products Program. REGRANEX, marketed by Janssen-Ortho Inc., is the
first of a new class of wound healing drugs, growth factors, that work by
actively stimulating the body's natural healing process so that the wound
fills with new, healthy tissue. This is a breakthrough for people with
diabetic foot ulcers - ulcers that often just don't heal, risking infection,
gangrene, amputation and even death.
STATIONS, FOR FURTHER INFORMATION, PLEASE CALL: Krista Webster, Deborah
Etsten, Julie Hoernig, or Leslie Wood at Lexicomm Communications,
(416) 368-0208. For technical information prior to the feed please call Joel
Rosenblum, CNW Broadcast, (416) 863-2096. During the feed call Dome
Productions at (416) 341-2001.
As with all CNW Broadcast feeds, this release is offered for your free
and unrestricted news use. Comments regarding content and quality are welcome. |
